Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients
Clinical trial NCT01335464 · COMPLETED
Trial details
- NCT number
- NCT01335464
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2013-10-01
- Enrollment
- 515
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.